Fig. 10From: A network pharmacology approach to reveal the pharmacological targets and biological mechanism of compound kushen injection for treating pancreatic cancer based on WGCNA and in vitro experiment validationMolecular docking of the core targets with its corresponding compound. Schematic diagram of the combination of A AKT1 and adenine; B MAPK1 and adenine; C MAPK3 and adenine; D EGFR and adenine; E EGFR and N-methylcytisine; F CDK1 and adenine; G CDK1 and lamprolobine; H JAK1 and 9α-hydroxymatrine; I JAK1 and sophoranolBack to article page